申请人:Warner-Lambert Company
公开号:US06245801B1
公开(公告)日:2001-06-12
Branched alkyl pyrrolidines of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, and neuropatnological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.
公开了式(I)的分支烷基吡咯烷,并且它们在治疗癫痫、晕厥发作、低动力症、颅内疾病、神经退行性疾病、抑郁症、焦虑症、惊恐症、疼痛和神经病理学疾病方面有用。还公开了制备过程和制备中有用的中间体。